influenza
commonli
occur
infecti
diseas
caus
capsular
rna
viru
influenza
viru
import
caus
respiratori
diseas
among
children
young
children
wellform
immun
system
influenza
infect
occur
first
year
life
studi
also
show
children
younger
year
age
high
rate
hospit
attribut
influenza
rate
compar
attribut
influenza
among
older
adult
izurieta
et
al
neuzil
et
al
healthi
children
includ
highrisk
group
vaccin
influenza
age
month
grohskopf
et
al
unfortun
percentag
vaccin
children
remain
low
level
name
throughout
mani
epidem
season
annual
level
vaccin
children
poland
year
stratifi
agegroup
follow
year
old
year
old
children
niphnih
low
estim
stark
contrast
verifi
effect
trival
vaccin
healthi
children
level
jefferson
et
al
nichol
decis
point
highli
protect
valu
influenza
vaccin
children
object
present
studi
examin
clinic
sampl
obtain
pediatr
patient
age
year
one
recent
epidem
season
poland
estim
frequenc
type
influenza
influenzalik
infect
studi
approv
institut
ethic
committe
conduct
comport
principl
biomed
human
research
set
declar
helsinki
epidem
season
ie
period
date
week
week
virolog
data
collect
within
framework
sentinel
nonsentinel
surveil
program
program
thought
repres
popul
sampl
countri
form
basi
deal
influenza
infect
subsequ
epidem
season
eight
hundr
two
clinic
specimen
patient
age
year
test
voivodeship
sanitari
epidemiolog
station
nation
influenza
center
nation
institut
public
health
nation
institut
hygien
niphnih
poland
specimen
consist
nasal
swab
throat
swab
bronchoalveolar
lavag
fluid
patient
stratifi
agegroup
year
old
year
old
year
old
epidemiolog
data
collect
sentinel
influenza
surveil
concern
year
old
year
old
children
viral
rna
extract
use
qiaamp
viral
rna
mini
kit
qiagen
hilden
germani
clinic
sampl
viral
transport
medium
consist
phosphatebuff
salin
accord
manufactur
instruct
rna
elut
rnasefre
water
multiplex
rtpcr
conduct
ace
detect
kit
seegen
seul
south
korea
assay
diagnost
panel
enabl
detect
respiratori
virus
influenza
viru
influenza
b
viru
human
respiratori
syncyti
viru
human
respiratori
syncyti
viru
b
human
adenoviru
human
metapneumoviru
human
coronaviru
human
coronaviru
human
parainfluenza
virus
human
rhinoviru
ab
product
random
hexamerprim
cdna
synthesi
gener
use
first
strand
cdna
synthesi
kit
fermenta
york
uk
accord
manufactur
instruct
store
use
cdna
prepar
subject
pcr
procedur
seegen
seoul
south
korea
system
enabl
simultan
detect
respiratori
virus
two
reaction
per
sampl
amplicon
detect
gel
electrophoresi
briefli
revers
transcript
pcr
amplif
perform
appli
biosystem
veriti
thermal
cycler
appli
biosystem
foster
citi
ca
accord
manufactur
instruct
epidem
season
total
influenza
influenzalik
ill
case
report
children
age
year
poland
incid
infect
per
children
distribut
agegroup
follow
case
year
age
incid
per
case
year
age
incid
per
fig
comparison
preced
epidem
season
total
case
incid
per
children
clinic
sampl
examin
present
studi
posit
virolog
result
obtain
sampl
test
sampl
posit
virolog
found
group
year
age
group
year
age
group
year
age
fig
influenza
virus
account
confirm
influenzalik
virus
detect
posit
sampl
molecular
biologybas
techniqu
confirm
infect
caus
influenza
type
sampl
includ
influenza
viru
unsubtyp
detect
case
subtyp
subtyp
case
genet
materi
influenza
b
detect
sampl
respect
confirm
influenzalik
virus
predomin
viru
rsv
mani
sampl
lower
percentag
detect
virus
account
famili
parainfluenza
addit
presenc
rotaviru
found
three
agegroup
epidem
season
predomin
influenza
infect
subtyp
viral
respiratori
infect
rsv
viru
data
diagnost
confirm
agegroup
talli
tabl
attent
paid
coinfect
respiratori
virus
six
possibl
coinfect
combin
report
poland
four
relat
children
year
age
tabl
overal
report
case
influenza
influenzalik
ill
children
age
year
epidem
season
poland
preced
season
total
incid
per
vs
incid
per
children
respect
find
studi
demonstr
frequent
incid
influenza
influenzalik
ill
concern
children
age
year
epidem
season
predomin
type
influenza
viru
season
viru
preced
season
viru
among
influenzalik
virus
season
predomin
viru
rsv
influenza
season
preced
season
note
sharp
increas
preval
influenza
type
b
viru
casual
factor
infect
account
posit
identifi
case
present
investig
sampl
season
compar
meager
preced
season
interestingli
number
confirm
influenza
type
b
viru
increas
increas
age
children
largest
proport
type
b
viru
note
group
year
age
fig
best
protect
influenza
children
immun
howev
mistaken
view
make
round
young
children
vaccin
american
academi
pediatr
us
center
diseas
control
prevent
advisori
committe
immun
practic
recommend
routin
influenza
immun
healthi
children
age
month
aim
reduc
influenza
incid
mortal
elderli
peopl
live
famili
along
children
fior
et
al
american
academi
pediatr
committe
infecti
diseas
recommend
vaccin
influenza
month
age
negri
et
al
shown
averag
efficaci
vaccin
children
age
month
year
efficaci
influenza
vaccin
affect
antigen
relationship
strain
includ
vaccin
circul
given
epidem
season
studi
conduct
joshi
et
al
shown
good
antigen
match
circul
includ
vaccin
virus
effect
vaccin
children
year
age
within
vaccin
children
signifi
reduct
treatment
cost
influenza
shown
cost
treat
influenza
children
year
age
higher
children
age
year
higher
cost
associ
parent
childcar
relat
absente
work
esposito
et
al
conclus
influenza
import
clinic
epidemiolog
econom
problem
adult
popul
also
children
influenza
infect
children
remain
undervalu
issu
